Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McQuade

Showing results (661-670 of 1,025) with videos related to

Pageof 103
Sort By:
Journal of Periodontology|April 1, 1989
Cotinine in saliva and gingival crevicular fluid of smokers with periodontal diseaseJ R McGuire, M J McQuade, J A Rossmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2014
Brexpiprazole II: antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulatorKenji Maeda, Linda Lerdrup, Haruhiko Sugino, et al.
Psych Journal|December 4, 2024
Online assessment in young children: Challenges and considerationsCatherine McBride, Jana Chi-San Ho, Maria McQuade, et al.
International Clinical Psychopharmacology|April 26, 2013
Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophreniaW Wolfgang Fleischhacker, Raymond Sanchez, Brian Johnson, et al.
NPJ Schizophrenia|June 24, 2016
Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label studyTimothy Peters-Strickland, Ross A Baker, Robert D McQuade, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 25, 2015
Effect of N-acetylcysteine infusion on exercise-induced modulation of insulin sensitivity and signaling pathways in human skeletal muscleAdam J Trewin, Leonidas S Lundell, Ben D Perry, et al.
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled studyGary Sachs, Raymond Sanchez, Ronald Marcus, et al.
Pharmacoepidemiology and Drug Safety|June 16, 2009
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic studyMarianne Ulcickas Yood, Gerald DeLorenze, Charles P Quesenberry, et al.
Hormone Research in Paediatrics|June 6, 2013
Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of ageM B Alcausin, J Briody, V Pacey, et al.
Current Medical Research and Opinion|July 5, 2013
Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazoleSteven G Potkin, Arash Raoufinia, Suresh Mallikaarjun, et al.
Pageof 103

Showing results (661-670 of 1,025) with videos related to

Sort By:
Pageof 103
Journal of Periodontology|April 1, 1989
Cotinine in saliva and gingival crevicular fluid of smokers with periodontal diseaseJ R McGuire, M J McQuade, J A Rossmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2014
Brexpiprazole II: antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulatorKenji Maeda, Linda Lerdrup, Haruhiko Sugino, et al.
Psych Journal|December 4, 2024
Online assessment in young children: Challenges and considerationsCatherine McBride, Jana Chi-San Ho, Maria McQuade, et al.
International Clinical Psychopharmacology|April 26, 2013
Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophreniaW Wolfgang Fleischhacker, Raymond Sanchez, Brian Johnson, et al.
NPJ Schizophrenia|June 24, 2016
Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label studyTimothy Peters-Strickland, Ross A Baker, Robert D McQuade, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 25, 2015
Effect of N-acetylcysteine infusion on exercise-induced modulation of insulin sensitivity and signaling pathways in human skeletal muscleAdam J Trewin, Leonidas S Lundell, Ben D Perry, et al.
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled studyGary Sachs, Raymond Sanchez, Ronald Marcus, et al.
Pharmacoepidemiology and Drug Safety|June 16, 2009
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic studyMarianne Ulcickas Yood, Gerald DeLorenze, Charles P Quesenberry, et al.
Hormone Research in Paediatrics|June 6, 2013
Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of ageM B Alcausin, J Briody, V Pacey, et al.
Current Medical Research and Opinion|July 5, 2013
Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazoleSteven G Potkin, Arash Raoufinia, Suresh Mallikaarjun, et al.
Pageof 103